Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Mission Bio Blog and Podcast go live! Get the latest news and trends on single-cell multi-omics. Subscribe
X
publication

Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome


Kennedy, A.L. et al.
Nature Communications (2021)
Abstract

To understand the mechanisms that mediate germline genetic leukemia predisposition, we studied the inherited ribosomopathy Shwachman-Diamond syndrome (SDS), a bone marrow failure disorder with high risk of myeloid malignancies at an early age. To define the mechanistic basis of clonal hematopoiesis in SDS, we investigate somatic mutations acquired by patients with SDS followed longitudinally. Here we report that multiple independent somatic hematopoietic clones arise early in life, most commonly harboring heterozygous mutations in EIF6 or TP53. We show that germline SBDS deficiency establishes a fitness constraint that drives selection of somatic clones via two distinct mechanisms with different clinical consequences. EIF6 inactivation mediates a compensatory pathway with limited leukemic potential by ameliorating the underlying SDS ribosome defect and enhancing clone fitness. TP53 mutations define a maladaptive pathway with enhanced leukemic potential by inactivating tumor suppressor checkpoints without correcting the ribosome defect. Subsequent development of leukemia was associated with acquisition of biallelic TP53 alterations. These results mechanistically link leukemia predisposition to germline genetic constraints on cellular fitness, and provide a rational framework for clinical surveillance strategies.



Authors

Kennedy, A.L., Myers K.C., Bowman, J., Gibson, C.J., Camarda, N.D., Furutani, E., Muscato, G.M., Klein, R.H., Ballotti, K., Liu, S., Harris, C.E., Galvin, A., Malsch, M., Dale, D., Gansner, J.M., Nakano, T.A., Bertuch, A., Vlachos, A., Lipton, J.M., Castillo, P., Connelly, J., Churpek, J., Edwards, J.R., Hijiya, N., Ho, R.H., Hofmann, I., Huang, J.N., Keel, S., Lamble, A., Lau, B.W., Norkin, M., Stieglitz, E., Stock, W., Walkovich, K., Boettcher, S., Brendel, C.,Fleming, M.D., Davies, S.M., Weller, E.A., Bahl, C., Carter, S.L., Shimamura, A., Lindsley, R.C.



VIEW

publication
Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma
Marin-Bejar, O.
Cancer Cell (2021)
publication
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias
Thijssen, R.
Blood (2021)
publication
Personalized single-cell proteogenomics to distinguish acute myeloid leukemia from nonmalignant clonal hematopoiesis
Dillon, L.W.
Blood Cancer Discovery (2021)
publication
PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism
Ren, A.A.
Nature (2021)